Heading Back to the Trough (Levels of Biologics in IBD)

被引：7
|
作者：
Hanauer, Stephen B. [1 ,2 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Med, Digest Hlth Clin, Chicago, IL USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 13卷 / 03期
关键词：
RHEUMATOID-ARTHRITIS PATIENTS; CROHNS-DISEASE; MAINTENANCE THERAPY; CLINICAL REMISSION; EPISODIC TREATMENT; INFLIXIMAB; ADALIMUMAB; ANTIBODY; DRUG; IMMUNOGENICITY;
D O I：
10.1016/j.cgh.2014.10.007
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：548 / 551
页数：4
相关论文
共 50 条
  • [1] Managing IBD patients on adalimumab based on trough levels and antibodies
    Parisi, I.
    Atherton, R.
    McCartney, S.
    Vega, R.
    Mehta, S.
    Whitley, L.
    Kabir, M.
    Kiparissi, F.
    Bloom, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S341 - S341
  • [2] Infliximab Serum Trough Levels and Deep Remission in Patients With IBD
    Drastich, Pavel
    Kozeluhova, Jana
    Jaresova, Marcela
    Spicak, Julius
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S292 - S292
  • [3] Biologics of IBD Foreword
    Falk, Gary W.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (03) : XIII - XIII
  • [4] High Infliximab Trough Levels Are Associated With Better Control of Inflammation in IBD
    Drobne, David
    Kurent, Tina
    Rajar, Polona
    Slak, Mateja
    Kozelj, Matic
    Novak, Gregor
    Smrekar, Natasa
    Plut, Samo
    Smid, Alojz
    Osredkar, Josko
    Stabuc, Borut
    Ferkolj, Ivan
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S422 - S423
  • [5] Biologics for Extraintestinal Manifestations of IBD
    Vavricka, Stephan R.
    Scharl, Michael
    Gubler, Martin
    Rogler, Gerhard
    [J]. CURRENT DRUG TARGETS, 2014, 15 (11) : 1064 - 1073
  • [6] The Usefulness of Serum Vitamin D Levels in the Assessment of IBD Activity and Response to Biologics
    Valvano, Marco
    Magistroni, Marco
    Mancusi, Antonio
    D'Ascenzo, Debora
    Longo, Salvatore
    Stefanelli, Gianpiero
    Vernia, Filippo
    Viscido, Angelo
    Necozione, Stefano
    Latella, Giovanni
    [J]. NUTRIENTS, 2021, 13 (02) : 1 - 10
  • [7] Early infliximab trough levels in paediatric IBD patients predict sustained remission
    Bevers, N.
    Aliu, A.
    Wong, D.
    Derijks, L.
    Winkens, B.
    Vreugdenhil, A.
    Pierik, M.
    Van Rheenen, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 581 - 582
  • [8] Residual Adalimumab Trough Levels Are Associated With Clinical Remission and Mucosal Healing in IBD
    Roblin, Xavier
    Marotte, Hubert
    Del Tedesco, Emilie
    Rinaudo-Gaujous, Melanie
    Phelip, Jean Marc
    Paul, Stephane
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S778 - S778
  • [9] Early infliximab trough levels in paediatric IBD patients predict sustained remission
    Bevers, Nanja
    Aliu, Arta
    Wong, Dennis R.
    Winkens, Bjorn
    Vreugdenhil, Anita
    Pierik, Marieke J.
    Derijks, Luc J. J.
    van Rheenen, Patrick F.
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [10] IFX SERUM LEVELS AT TROUGH DO NOT ADEQUATELY REFLECT EXPOSURE IN IBD PATIENTS
    Berends, Sophie E.
    Mathot, Ron
    Strik, Anne S.
    de Vries, Annick
    Lowenberg, Mark
    D'Haens, Geert R.
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S1137 - S1138
12345